News & Opinion

» opinion and cancer

Covering the life sciences inside and out

Most Recent

image: Opinion: Of Mice and Men

Opinion: Of Mice and Men

By | December 3, 2013

Researchers scramble to put mouse cancer models on solid footing.

1 Comment

image: Gut Flora Boost Cancer Therapies

Gut Flora Boost Cancer Therapies

By | November 21, 2013

Researchers scramble to put mouse cancer models on solid footing.

2 Comments

image: Temperature-Dependent Immunity

Temperature-Dependent Immunity

By | November 18, 2013

Researchers scramble to put mouse cancer models on solid footing.

8 Comments

image: Retracing Steps

Retracing Steps

By | November 11, 2013

Researchers scramble to put mouse cancer models on solid footing.

1 Comment

image: Next Generation: Cancer Drug in Disguise

Next Generation: Cancer Drug in Disguise

By | November 5, 2013

Researchers scramble to put mouse cancer models on solid footing.

2 Comments

image: Decoding Breast Cancer Drug Resistance

Decoding Breast Cancer Drug Resistance

By | November 3, 2013

Researchers scramble to put mouse cancer models on solid footing.

2 Comments

image: It’s in the Genes

It’s in the Genes

By | October 24, 2013

Researchers scramble to put mouse cancer models on solid footing.

4 Comments

image: Different Cancers, Same Mutations

Different Cancers, Same Mutations

By | September 26, 2013

Researchers scramble to put mouse cancer models on solid footing.

4 Comments

image: Opinion: Reasons for the R&D Crisis

Opinion: Reasons for the R&D Crisis

By | September 23, 2013

Researchers scramble to put mouse cancer models on solid footing.

2 Comments

image: Opinion: How HIV Became Positive

Opinion: How HIV Became Positive

By | September 17, 2013

Researchers scramble to put mouse cancer models on solid footing.

1 Comment

Popular Now

  1. How Plants Evolved Different Ways to Make Caffeine
  2. Thomson Reuters Predicts Nobelists
    The Nutshell Thomson Reuters Predicts Nobelists

    According to citation statistics, researchers behind programmed cell death pathways and CRISPR/Cas9 are among those in line for Nobel Prizes this year.

  3. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  4. Reviewing Results-Free Manuscripts
    The Nutshell Reviewing Results-Free Manuscripts

    An open-access journal is trialing a peer-review process in which reviewers do not have access to the results or discussion sections of submitted papers.

RayBiotech